GlassScriptPhysician profile
Andrew Marsala
NPI 1477846269
$3,090.86
in general payments reported to CMS, 2019-2025
12 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.62 · 2020: $163 · 2021: $118 · 2022: $1,574 · 2023: $1,017 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $1,221.95 | 2022-2023 | Trinav Infusion System |
| Cardiva Medical, INC. | $697.19 | 2022-2023 | Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs |
| Boston Scientific Corporation | $396.83 | 2020-2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Terumo Medical Corporation | $166.09 | 2019-2023 | Angio-Seal, Hydropearl, Azur Cx Detachable |
| Inari Medical, INC. | $147.91 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $147.00 | 2025 | Indigo System |
| W. L. Gore & Associates, INC. | $129.87 | 2022 | |
| Ethicon US, LLC | $66.45 | 2020-2023 | Neuwave |
| Ipsen Biopharmaceuticals, INC | $59.45 | 2023 | Somatuline Depot |
| Teva Pharmaceuticals USA, INC. | $26.81 | 2025 | Uzedy |
| Ge Healthcare | $19.48 | 2019-2020 | |
| Covidien LP | $11.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Marsala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.